Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 3 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.


Player Avatar TMFBiologyFool (96.86) Submitted: 5/7/2012 10:49:11 AM : Underperform Start Price: $2.73 ARNA Score: -239.73

Not convinced the company has satisfied the FDA's safety concerns.

Featured Broker Partners